Stock Under $10 with 50-100% upside potential - 14 Days FREE!

DePuy ASR Lawsuit Update: Toxicologist Testifies That Plaintiff Kransky Has High Levels Of Metal In His Blood

LOS ANGELES, Feb. 4, 2013 /PRNewswire/ -- The Rottenstein Law Group, which represents hip implant clients, is closely monitoring the proceedings of the Los Angeles DePuy trial (In re: Loren Kransky and Sheryl Kransky v. DePuy, Inc., et al., BC456086, Los Angeles Superior Court) and is featuring those updates on our  DePuy ASR Hip Recall Information Center.

(Logo:   http://photos.prnewswire.com/prnh/20130204/NY53632LOGO )

On Friday, Feb. 1., Dr. Robert Harrison, a toxicologist, testified on the harm caused by the metals cobalt and chromium when they enter a person's bloodstream. Harrison testified that after carefully reviewing Kransky's medical records he determined that Kransky suffers from elevated levels of metal ions in his bloodstream, the Rottenstein Law Group reports after reviewing live testimony from the trial via the Courtroom View Network.*

Harrison, who has written more than 40 academic articles about toxicology, said he had received calls from several patients concerned about elevated levels of metal in their bloodstream. The patients had received metal-on-metal hip implants such the DePuy ASR. He said that Kransky had "seven or eight times the level set by the California Poison Control department."

The dangers of metal poisoning, also called "metallosis," are twofold, Harrison said. One is what he called "local damage," which is damage to the tissue around the DePuy ASR hip implant. Cells and genes can be altered by sustained exposure to high levels of cobalt and chromium, he said. The other danger is "systemic," he said, in which the metal ions are carried throughout the body, which can affect the central nervous system. Harrison also testified that the medical and science communities have known about the dangers of metal poisoning from metal implant components since the 1970s.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,294.50 -12.67 -0.08%
NASDAQ 3,459.42 -3.88 -0.11%
S&P 500 1,650.51 -4.84 -0.29%
US 10 Yr 2.023% -0.003

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs